Although loss of Fas or Fas-L ligand are rarely present in SLE patients27 and can be seen as an apparent limitation of the MRL model, Fas and Fas ligand gene polymorphism is associated with risk of developing SLE28,29. Here, FASLG is linked to systemic lupus erythematosus.